Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.34%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc (TTH.TO)

-Toronto
2.83 0.00(0.00%) 11:23AM EDT
Add to Portfolio
Prev Close:2.83
Open:3.00
Bid:2.76
Ask:2.86
1y Target Est:N/A
Beta:0.66
Earnings Date:Sep 14 - Sep 18 (Est.)
Day's Range:2.83 - 3.00
52wk Range:2.50 - 11.50
Volume:1,000
Avg Vol (3m):11,072
Market Cap:109.97M
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-15) :-1.22
Quarterly EPS Est (Jun-15) :N/A
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback